1.
Kobayashi A, Mugford JW, Krautzberger M, Naiman N, Liao J, McMahon AP. Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Reports. 2014;3(4):650-62. doi:10.1016/j.stemcr.2014.08.008.
1.
Bernstein BE, Kamal M, Lindblad-Toh K, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 2005;120(2):169-81. doi:10.1016/j.cell.2005.01.001.
1.
Pasque V, Tchieu J, Karnik R, et al. X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency. Cell. 2014;159(7):1681-97. doi:10.1016/j.cell.2014.11.040.
1.
Coletta RD, Christensen K, Reichenberger KJ, et al. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A. 2004;101(17):6478-83. doi:10.1073/pnas.0401139101.
1.
Shakya A, Callister C, Goren A, et al. Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion. Mol Cell Biol. 2015;35(6):1014-25. doi:10.1128/MCB.01105-14.
1.
Onder TT, Kara N, Cherry A, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012;483(7391):598-602. doi:10.1038/nature10953.
1.
Etchegaray J-P, Chavez L, Huang Y, et al. The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine. Nat Cell Biol. 2015;17(5):545-57. doi:10.1038/ncb3147.
1.
Fancy SPJ, Glasgow SM, Finley M, Rowitch DH, Deneen B. Evidence that nuclear factor IA inhibits repair after white matter injury. Ann Neurol. 2012;72(2):224-33. doi:10.1002/ana.23590.
1.
Cannon D, Corrigan AM, Miermont A, McDonel P, Chubb JR. Multiple cell and population-level interactions with mouse embryonic stem cell heterogeneity. Development. 2015;142(16):2840-9. doi:10.1242/dev.120741.
1.
Ren Y, Cheung HW, von Maltzhan G, et al. Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med. 2012;4(147):147ra112. doi:10.1126/scitranslmed.3003778.